| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | MetaVia Inc.: MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity | 1.814 | PR Newswire | 16-Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults
CAMBRIDGE, Mass., April 10, 2026... ► Artikel lesen | |
| Fr | eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast | 654 | ACCESS Newswire | LOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals... ► Artikel lesen | |
| Fr | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.04.2026 | 582 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 10.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.04.2026.ISIN NameAU000000ICI5... ► Artikel lesen | |
| Fr | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 477 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| Fr | Weekly Buzz: MacroGenics Resumes LINNET; GSK Wins China Nod; FDA Okays Waters Corporation; Neurocrine Biosciences Snaps Up Soleno Therapeutics | 467 | AFX News | THOUSAND OAKS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Canada, and China, alongside the lifting of a clinical trial hold by the FDA, collaborations... ► Artikel lesen | |
| Fr | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 453 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| Fr | Sharp Therapeutics Corp.: Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering | 390 | Newsfile | Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it... ► Artikel lesen | |
| Fr | BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications | 367 | GlobeNewswire (Europe) | NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the "Company") today announced that it has completed the acquisition of 100% of Zorronet from... ► Artikel lesen | |
| Fr | Sharp Therapeutics Corp.: Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs | 345 | Newsfile | Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces that following longer-term... ► Artikel lesen | |
| Fr | Water Tower Research: NurExone to Participate in Water Tower Research Insights Conference on April 14, 2026 | 327 | Newsfile | Toronto, Ontario and Haifa, Israel--(Newsfile Corp. - April 10, 2026) - NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a biotechnology company developing... ► Artikel lesen | |
| Fr | Idorsia Pharmaceuticals Ltd: Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders | 326 | GlobeNewswire (Europe) | Allschwil, Switzerland - April 10, 2026Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting... ► Artikel lesen | |
| Fr | Notice of Faron Pharmaceuticals LTD's Annual General Meeting | 311 | ACCESS Newswire | TURKU, FI / ACCESS Newswire / April 10, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Shareholders of Faron Pharmaceuticals Ltd (the "Company") are notified of the Annual General Meeting (the... ► Artikel lesen | |
| 02:02 | Lobe Sciences Ltd. Announces Non-Brokered Private Placement | 301 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC / ACCESS Newswire / April 10, 2026 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE)... ► Artikel lesen | |
| Fr | XFRA 7R8: AUSSETZUNG/SUSPENSION | 242 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILREPLIMUNE GR. INC... ► Artikel lesen | |
| Fr | Number of Shares and Voting Rights of ADOCIA as of March 31st, 2026 | 203 | Business Wire | Regulatory News:
Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of the French stock-market authorities (Autorité... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| BB BIOTECH | 48,350 | 2,47 | +5,11 % | 2,25 | 23.03.2026 | |
| CSL | 84,15 | 2,61 | +3,10 % | 1,84 | 10.03.2026 | |
| AMGEN | 299,00 | 8,27 | +2,77 % | 2,52 | 15.05.2026 | |
| RECORDATI | 48,960 | 1,30 | +2,66 % | 0,71 | 18.05.2026 | |
| NOVONESIS | 50,86 | 0,87 | +1,71 % | 4,25 | 20.03.2026 | |
| SINO BIOPHARM | 0,630 | 0,01 | +1,59 % | 0,05 | 24.06.2026 | |
| GENUS | 29,400 | 0,38 | +1,29 % | 0,11 | 05.03.2026 | |
| 3SBIO | 2,554 | 0,03 | +1,17 % | 0,25 | 21.07.2026 | |
| VITROLIFE | 8,920 | 0,10 | +1,12 % | 1,10 | 06.05.2026 | |
| BIOMERIEUX | 90,00 | 0,90 | +1,00 % | 0,98 | 09.06.2026 |